101 related articles for article (PubMed ID: 21039327)
1. What are the individual perceptions of patients with borderline tumours of the ovary in regard to pathogenesis and prognosis? A structured survey on 60 women.
Fotopoulou C; Bugariu M; Braicu EI; Lichtenegger W; Sehouli J
J Psychosom Obstet Gynaecol; 2010 Dec; 31(4):265-72. PubMed ID: 21039327
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of ovarian cryopreservation in borderline ovarian tumours.
Fain-Kahn V; Poirot C; Uzan C; Prades M; Gouy S; Genestie C; Duvillard P; Morice P
Hum Reprod; 2009 Apr; 24(4):850-5. PubMed ID: 19098070
[TBL] [Abstract][Full Text] [Related]
3. Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group.
du Bois A; Ewald-Riegler N; de Gregorio N; Reuss A; Mahner S; Fotopoulou C; Kommoss F; Schmalfeldt B; Hilpert F; Fehm T; Burges A; Meier W; Hillemanns P; Hanker L; Hasenburg A; Strauss HG; Hellriegel M; Wimberger P; Keyver-Paik MD; Baumann K; Canzler U; Wollschlaeger K; Forner D; Pfisterer J; Schröder W; Münstedt K; Richter B; Kommoss S; Hauptmann S;
Eur J Cancer; 2013 May; 49(8):1905-14. PubMed ID: 23490647
[TBL] [Abstract][Full Text] [Related]
4. Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors.
Zanagnolo V; Sartori E; Trussardi E; Pasinetti B; Maggino T
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):235-43. PubMed ID: 15921842
[TBL] [Abstract][Full Text] [Related]
5. [Borderline tumors of the ovary. New aspects on morphologic prognosis determination].
Dietel M; Bodecker R; Arps H; Bahnsen J; Hölzel F
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):213-9. PubMed ID: 3891502
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort.
Lenhard MS; Mitterer S; Kümper C; Stieber P; Mayr D; Ditsch N; Friese K; Burges A
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):189-94. PubMed ID: 19477060
[TBL] [Abstract][Full Text] [Related]
7. Recurrence and prognostic factors in borderline ovarian tumors.
Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
[TBL] [Abstract][Full Text] [Related]
8. Fertility preserving surgical treatment of borderline ovarian tumour: long-term consequence for fertility and recurrence.
Marcickiewicz J; Brännström M
Acta Obstet Gynecol Scand; 2006; 85(12):1496-500. PubMed ID: 17260228
[TBL] [Abstract][Full Text] [Related]
9. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2009 Apr; 113(1):75-82. PubMed ID: 19171373
[TBL] [Abstract][Full Text] [Related]
10. Prognosis and management of borderline tumours of the ovary.
Tropé C; Kaern J
Curr Opin Obstet Gynecol; 1996 Feb; 8(1):12-6. PubMed ID: 8777251
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
Suh-Burgmann E
Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
13. Women's awareness of ovarian cancer risks and symptoms.
Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and pathological features of borderline ovarian tumors].
Li Y; Cui H; Shen DH; Zhao Y; Wei LH; Qian HN
Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):81-4. PubMed ID: 12783693
[TBL] [Abstract][Full Text] [Related]
15. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
[TBL] [Abstract][Full Text] [Related]
16. Recurrence after cystectomy for borderline ovarian tumors: results of a French multicenter study.
Poncelet C; Fauvet R; Boccara J; Daraï E
Ann Surg Oncol; 2006 Apr; 13(4):565-71. PubMed ID: 16491337
[TBL] [Abstract][Full Text] [Related]
17. Requirement for expert histopathological assessment of ovarian cancer and borderline tumors.
Sengupta PS; Shanks JH; Buckley CH; Ryder WD; Davies J; Reynolds K; Slade RJ; Kitchener HC; Jayson GC
Br J Cancer; 2000 Feb; 82(4):760-2. PubMed ID: 10732741
[TBL] [Abstract][Full Text] [Related]
18. [Laparoscopic preliminary surgery of ovarian malignancies. Experiences from 127 German gynecologic clinics].
Kindermann G; Maassen V; Kuhn W
Geburtshilfe Frauenheilkd; 1995 Dec; 55(12):687-94. PubMed ID: 8582588
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors.
Begum FD; Høgdall E; Kjaer SK; Blaakaer J; Christensen IJ; Christensen L; Høgdall C
Gynecol Oncol; 2009 May; 113(2):221-7. PubMed ID: 19261323
[TBL] [Abstract][Full Text] [Related]
20. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
